We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Clarivate (CLVT) to Develop Unified Library Solution for Ohio
Read MoreHide Full Article
Clarivate Plc (CLVT - Free Report) recently partnered with OhioLINK and SearchOhio to integrate their INN-Reach platforms. Together, these three entities will develop a unified library solution for Ohio. The unification of OhioLINK and SearchOhio’s resource platforms will enrich the database, giving the users extended choices.
Users will now be able to access content from 87 institutions and 45 public library systems throughout the state of Ohio. This partnership will also enable Clarivate to simplify resource sharing across libraries.
This partnership with OhioLINK and SearchOhio will help CLVT expand its market presence in the academic space.
Clarivate provides its technology solutions to academia, government, intellectual property, life sciences and healthcare markets. Its Academia and Government segment accounted for 50% of its revenues in 2023.
CLVT seems to capitalize on the growing academic software market. Per a report by Future Data Stats, the global educational software market is projected to witness a CAGR of 8.2% from 2024 to 2030.
The company has expanded its presence in the academia market in the past year with a number of business moves. Clarivate collaborated with EveryLibrary and Yale University, renewed its partnership with The Federal Library, launched the Academia & Government Innovation Incubator and acquired artificial intelligence-based student engagement solution, Alethea.
Clarivate Faces Near-Term Challenges
Clarivate faced an organic decline in its top line in the first quarter of 2024. This decline can be attributed to a decrease in non-subscription revenues of the company. Organizations are facing budgetary challenges due to still high interest rates and persistent macroeconomic headwinds, leading them to delay their plans. The company also expects exchange rate headwinds throughout 2024.
CLVT was also facing minimal growth and low potential from its Valipat business, so it sold the asset in April 2024. This might have a temporary effect on the company’s top line by reducing revenues by $30 million. However, the sale of the Valipat business will help Clarivate focus on high-growth business divisions.
Conclusion
Clarivate is expanding its capabilities through partnerships. However, a number of factors are weighing down the company’s performance. Besides macroeconomic challenges, the company also faces enormous competitive pressure in the analytics and intelligence space.
In the healthcare and life science space where Clarivate provides analytics and intelligence, big players like IQVIA (IQV - Free Report) , Oracle’s (ORCL - Free Report) Cerner and Dassault Systems’ (DASTY - Free Report) Medidata Solutions operate. These organizations have substantial financial resources, renowned brand names and technological expertise.
Cerner and Medidata were some of the most popular healthcare intelligence providers, which now enjoy the resources provided by big organizations like Oracle and Dassault respectively. Moreover, IQVIA has been in the information intelligence market since the 1980s, giving its significant market experience over Clarivate which entered this space much later.
CLVT also faces the risk of a growing number of inexpensive information sources driven by technological advancements, which could reduce the demand for its products and services in the long run.
Image: Bigstock
Clarivate (CLVT) to Develop Unified Library Solution for Ohio
Clarivate Plc (CLVT - Free Report) recently partnered with OhioLINK and SearchOhio to integrate their INN-Reach platforms. Together, these three entities will develop a unified library solution for Ohio. The unification of OhioLINK and SearchOhio’s resource platforms will enrich the database, giving the users extended choices.
Users will now be able to access content from 87 institutions and 45 public library systems throughout the state of Ohio. This partnership will also enable Clarivate to simplify resource sharing across libraries.
This partnership with OhioLINK and SearchOhio will help CLVT expand its market presence in the academic space.
Clarivate PLC Price and Consensus
Clarivate PLC price-consensus-chart | Clarivate PLC Quote
Expanding Partner Base Aids Clarivate
Clarivate provides its technology solutions to academia, government, intellectual property, life sciences and healthcare markets. Its Academia and Government segment accounted for 50% of its revenues in 2023.
CLVT seems to capitalize on the growing academic software market. Per a report by Future Data Stats, the global educational software market is projected to witness a CAGR of 8.2% from 2024 to 2030.
The company has expanded its presence in the academia market in the past year with a number of business moves. Clarivate collaborated with EveryLibrary and Yale University, renewed its partnership with The Federal Library, launched the Academia & Government Innovation Incubator and acquired artificial intelligence-based student engagement solution, Alethea.
Clarivate Faces Near-Term Challenges
Clarivate faced an organic decline in its top line in the first quarter of 2024. This decline can be attributed to a decrease in non-subscription revenues of the company. Organizations are facing budgetary challenges due to still high interest rates and persistent macroeconomic headwinds, leading them to delay their plans. The company also expects exchange rate headwinds throughout 2024.
CLVT was also facing minimal growth and low potential from its Valipat business, so it sold the asset in April 2024. This might have a temporary effect on the company’s top line by reducing revenues by $30 million. However, the sale of the Valipat business will help Clarivate focus on high-growth business divisions.
Conclusion
Clarivate is expanding its capabilities through partnerships. However, a number of factors are weighing down the company’s performance. Besides macroeconomic challenges, the company also faces enormous competitive pressure in the analytics and intelligence space.
In the healthcare and life science space where Clarivate provides analytics and intelligence, big players like IQVIA (IQV - Free Report) , Oracle’s (ORCL - Free Report) Cerner and Dassault Systems’ (DASTY - Free Report) Medidata Solutions operate. These organizations have substantial financial resources, renowned brand names and technological expertise.
Cerner and Medidata were some of the most popular healthcare intelligence providers, which now enjoy the resources provided by big organizations like Oracle and Dassault respectively. Moreover, IQVIA has been in the information intelligence market since the 1980s, giving its significant market experience over Clarivate which entered this space much later.
CLVT also faces the risk of a growing number of inexpensive information sources driven by technological advancements, which could reduce the demand for its products and services in the long run.
Shares of this Zacks Rank #3 (Hold) company have plunged 28.8% in the year-to-date period against the Zacks Internet - Software industry’s growth of 8%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.